Cardiotoxicity of Cancer Treatments (Q169023): Difference between revisions

Latest revision as of 21:10, 12 September 2024

Investigating heart damage from cancer treatments.

Language	Label	Description	Also known as
English	Cardiotoxicity of Cancer Treatments	Investigating heart damage from cancer treatments.

0 references

0 references

@@ aliases / en / 0 / aliases / en / 0 @@
-Anthracyclines
@@ aliases / en / 1 / aliases / en / 1 @@
-Doxorubicin
@@ aliases / en / 2 / aliases / en / 2 @@
-Cardiomyopathy
@@ aliases / en / 3 / aliases / en / 3 @@
-Chemotherapy
@@ aliases / en / 4 / aliases / en / 4 @@
-Cardiovascular Complications
@@ aliases / en / 5 / aliases / en / 5 @@
-Trastuzumab
@@ aliases / en / 6 / aliases / en / 6 @@
-Oxidative Stress
@@ aliases / en / 7 / aliases / en / 7 @@
-Cardiac Dysfunction
@@ aliases / en / 8 / aliases / en / 8 @@
-Prevention
@@ aliases / en / 9 / aliases / en / 9 @@
-Survivors
@@ description / en / description / en @@
-This cluster of papers focuses on the cardiotoxic effects of various cancer treatments, particularly anthracyclines and related drugs like doxorubicin and trastuzumab
+Investigating heart damage from cancer treatments.
@@ Property / same as @@
-https://openalex.org/T11535
@@ Property / same as: https://openalex.org/T11535 / rank @@
-Normal rank
@@ Property / OpenAlex ID @@
+T11535
@@ Property / OpenAlex ID: T11535 / rank @@
+Normal rank